CD20, Columvi, DLBCL, Genentech
Glofitamab-gxbm waxa u ansixisay FDA ee la xushay soo noqoshada ama dib u soo noqoshada unugyada B-cell lymphomas
July 2023: The Food and Drug Administration gave accelerated approval to glofitamab-gxbm (Columvi, Genentech, Inc.) for relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) or large B-cell ly..
Qanjirka 'B-cell lymphoma', DLBCL, POLARIX, Polatuzumab, polatuzumab vedotin
Polatuzumab vedotin-piiq waxa ansixisay USFDA si aan hore loo daawayn firidhsan B-cell lymfoma, aan si kale loo cayimin, iyo heerka sare ee B-cell lymphoma
Meey 2023: Bukaanada qaangaarka ah ee leh heerka sare ee B-cell lymphoma (HGBL), aan si kale loo cayimin (NOS), ama faafin B-cell lymphoma (DLBCL) oo aan horay loo helin daweyn oo leh Inde Prognostic International.
CAR - T Daaweynta unugyada, Hal qayb oo ka mid ah CARsgen Therapeutics Co., Ltd, Shirkadda Daiichi Sankyo, DLBCL, Cilmi-baadhis degdeg ah, Xaddidan, Novartis AG
CAR T-Cell therapy suuqa ayaa ku kori doona heer cajiib ah 8 sano ee soo socota
Luulyo 2022: Marka loo eego cilmi-baaristii ugu dambeysay ee ay sameysay Cilmi-baarista Emergen, suuqa adduunka ee daaweynta unugyada CAR T-cells wuxuu gaaray cabbir dhan USD 1.29 bilyan sanadka 2021 waxaana la filayaa inuu diiwaangeliyo dakhli CAGR ah 24.9 boqolkiiba ..
Burkitt lymphoma, Burkitt u eg lymphoma, DLBCL, Genentech, Rituxan, Rituximab
Rituximab plus chemotherapy waxaa u ogolaatay FDA ee tilmaamayaasha kansarka carruurta
Maarso 2022: Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay rituximab (Rituxan, Genentech, Inc.) iyada oo lala kaashanayo kiimoterabiga loogu talagalay CD20-positive diffuse big B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma.
Hal qayb oo ka mid ah ADC Therapeutics SA, wakiilka alkylating isku xidh, Kahortaga CD19 ee jiheeye, Kalasaarka ballaaran ee unugyada unugyada 'B-cell lymphoma', DLBCL, lymphoma-B-unug-heer sare ah, Lymphoma-ka weyn ee B-cell, Loncastuximab tesirine-lpyl, Zynlonta
FDA waxay oggolaatay loncastuximab tesirine-lpyl oo la dedejiyey oggolaanshaha lymphoma-ka weyn ee B
Ogosto 2021: FDA waxay siisay loncastuximab tesirine-lpyl (Zynlonta, ADC Therapeutics SA), antibody-CD-directed antibody iyo alkylating conjugate, ansixinta dardargelinta bukaanada qaangaarka ah
DLBCL, Lymphoma Hodgkin, qanjiro, NHL, Non Hodgkin lymphoma
Maxay dadka dhallin-yarada ah ugu dhacaan cudurrada 'lymphoma' badan?
LymphDadku waxay leeyihiin aqoon aad u yar oo ku saabsan lymfa. Luqunta, gumaarka, iyo kilkilooyinka dhammaantood waa limfa. Haddii ay dhibaato ka timaado habka lymfatic-ka, sunta jidhku waxay ku kaydin doontaa jidhka tiro aad u badan, lymphoma ayaa dhawaan dhici doonta.